Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Current Liabilities ₹973 Cr₹683 Cr₹710 Cr₹526 Cr₹685 Cr

What is the latest Total Current Liabilities ratio of NATCO PHARMA ?

The latest Total Current Liabilities ratio of NATCO PHARMA is ₹973 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹973 Cr
Mar2023₹683 Cr
Mar2022₹710 Cr
Mar2021₹526 Cr
Mar2020₹685 Cr

How is Total Current Liabilities of NATCO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2024 ₹973 Cr
42.41
Mar2023 ₹683 Cr
-3.84
Mar2022 ₹710 Cr
35.16
Mar2021 ₹526 Cr
-23.30
Mar2020 ₹685 Cr -

Compare Total Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,711.8 Cr 6.2% 6.2% -19.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,017.0 Cr -0.2% -0.5% 10.7% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4% 4.8% 50.5% Stock Analytics
CIPLA ₹122,451.0 Cr 0.4% 3.1% 1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,620.0 Cr 5.9% 9.1% 23% Stock Analytics
DR REDDYS LABORATORIES ₹106,572.0 Cr -4.8% 2.2% 2.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

6.2%

6.2%

-19.5%

SENSEX

2%

2.8%

6.4%


You may also like the below Video Courses